Hiyama K - Search Results

1

Non-RI protocols for L-myc allelotyping and deletion mapping of chromosome 1p in primary lung cancers.

Hiyama K, Mendoza C, Hiyama E. Hiyama K, et al. Among authors: hiyama e. Methods Mol Med. 2003;74:231-9. doi: 10.1385/1-59259-323-2:231. Methods Mol Med. 2003. PMID: 12415698 No abstract available.

2

Detection of telomerase activity in lung cancer tissues.

Hiyama K, Hiyama E. Hiyama K, et al. Among authors: hiyama e. Methods Mol Med. 2003;74:401-12. doi: 10.1385/1-59259-323-2:401. Methods Mol Med. 2003. PMID: 12415711 No abstract available.

3

Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.

Mendoza C, Sato H, Hiyama K, Ishioka S, Isobe T, Maeda H, Hiyama E, Inai K, Yamakido M. Mendoza C, et al. Among authors: hiyama k, hiyama e. Lung Cancer. 2000 May;28(2):117-25. doi: 10.1016/s0169-5002(99)00125-7. Lung Cancer. 2000. PMID: 10717329

4

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.

Komatsu M, Hiyama K, Tanimoto K, Yunokawa M, Otani K, Ohtaki M, Hiyama E, Kigawa J, Ohwada M, Suzuki M, Nagai N, Kudo Y, Nishiyama M. Komatsu M, et al. Among authors: hiyama k, hiyama e. Mol Cancer Ther. 2006 Mar;5(3):767-75. doi: 10.1158/1535-7163.MCT-05-0408. Mol Cancer Ther. 2006. PMID: 16546992

5

Clinical utility of telomerase in cancer.

Hiyama E, Hiyama K. Hiyama E, et al. Among authors: hiyama k. Oncogene. 2002 Jan 21;21(4):643-9. doi: 10.1038/sj.onc.1205070. Oncogene. 2002. PMID: 11850791 Review.

6

[Telomere and telomerase in lung cancer].

Hiyama K, Hiyama E. Hiyama K, et al. Among authors: hiyama e. Nihon Rinsho. 2002 May;60 Suppl 5:737-42. Nihon Rinsho. 2002. PMID: 12101775 Review. Japanese. No abstract available.

7

Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.

Hiyama E, Hiyama K, Nishiyama M, Reynolds CP, Shay JW, Yokoyama T. Hiyama E, et al. Among authors: hiyama k. J Pediatr Surg. 2003 Dec;38(12):1730-4. doi: 10.1016/j.jpedsurg.2003.08.042. J Pediatr Surg. 2003. PMID: 14666454

8

Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb.

Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T, Yamakido M. Hiyama K, et al. Among authors: hiyama e. Oncogene. 1995 Mar 2;10(5):937-44. Oncogene. 1995. PMID: 7898935

9

Alteration in length of telomeric repeats in lung cancer.

Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, Yonehara S, Yoshida Y, Inai K, Hiyama E, Hasegawa K, et al. Shirotani Y, et al. Among authors: hiyama k, hiyama e. Lung Cancer. 1994 Jul;11(1-2):29-41. doi: 10.1016/0169-5002(94)90280-1. Lung Cancer. 1994. PMID: 8081703

10

[Telomerase activity as a novel marker of lung cancer].

Hiyama K, Ishioka S, Hiyama E, Yamakido M. Hiyama K, et al. Among authors: hiyama e. Nihon Rinsho. 1998 May;56(5):1253-7. Nihon Rinsho. 1998. PMID: 9613133 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters